Patents by Inventor Philippe Schmitt

Philippe Schmitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10857128
    Abstract: The present invention relates to a food composition and a pharmaceutical comprising D-tryptophan. The present invention further relates to D-tryptophan for use in the treatment, prevention or amelioration of a diseases associated with Treg or TH2 cells, such as allergy and in particular asthma.
    Type: Grant
    Filed: September 19, 2017
    Date of Patent: December 8, 2020
    Assignee: Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
    Inventors: Susanne Krauss-Etschmann, Anton Hartmann, Philippe Schmitt-Kopplin, Michael Schloter
  • Patent number: 10323043
    Abstract: The present invention relates to a compound with the following formula (I): (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: June 18, 2019
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir Kaloun, Serge Grisoni, Anna Kruczynski, Philippe Schmitt
  • Publication number: 20190083461
    Abstract: The present invention relates to a food composition and a pharmaceutical comprising D-tryptophan. The present invention further relates to D-tryptophan for use in the treatment, prevention or amelioration of a diseases associated with Treg or TH2 cells, such as allergy and in particular asthma.
    Type: Application
    Filed: September 19, 2017
    Publication date: March 21, 2019
    Inventors: Susanne Krauss-Etschmann, Anton Hartmann, Philippe Schmitt-Kopplin, Michael Schloter
  • Patent number: 10024446
    Abstract: A multi-way valve includes an outer casing provided with an internal cavity, at least one input to the cavity, at least one output from the cavity, the at least one input having sealing means, and an actuator adapted to cause the opening of the sealing means of the inputs. A cross-section of the actuator is smaller than a cross-section of the inner cavity.
    Type: Grant
    Filed: December 16, 2016
    Date of Patent: July 17, 2018
    Assignee: GE Energy Products France SNC
    Inventors: Mohamad Maher Aboujaib, Philippe Schmitt, Jean Louis Vignolo, Ezio Mauricio Pena, Sven Catrin
  • Patent number: 9944641
    Abstract: The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a drug, notably in the treatment of cancer, as well as pharmaceutical compositions containing such a compound and processes to prepare such a compound.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: April 17, 2018
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir Kaloun, Philippe Schmitt, Anna Kruczynski
  • Patent number: 9938820
    Abstract: A downhole gas detection tool includes a housing; a first test module that includes a first fluid test chamber operable to fluidly couple to an annulus of a wellbore to receive a first portion of a wellbore fluid, the first test module further including an acoustic fluid sensor to measure a fluid acoustic velocity and attenuation of the first portion of the wellbore fluid received in the first fluid test chamber, and a fluid resistivity sensor to measure a fluid resistivity of the first portion of the wellbore fluid received in the first fluid test chamber; and a second test module including a second fluid test chamber operable to fluidly couple to the annulus of the wellbore to receive a second portion of the wellbore fluid, and a pressure-temperature (PT) sensor to measure at least one of a pressure or a temperature of the second portion of the wellbore fluid.
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: April 10, 2018
    Assignee: Saudi Arabian Oil Company
    Inventors: Clovis Satyro Bonavides, Denis Philippe Schmitt, Mohd Azizi Ibrahim
  • Publication number: 20170314691
    Abstract: A multi-way valve includes an outer casing provided with an internal cavity, at least one input to the cavity, at least one output from the cavity, the at least one input having sealing means, and an actuator adapted to cause the opening of the sealing means of the inputs. A cross-section of the actuator is smaller than a cross-section of the inner cavity.
    Type: Application
    Filed: December 16, 2016
    Publication date: November 2, 2017
    Inventors: Mohamad Maher Aboujaib, Philippe Schmitt, Jean Louis Vignolo, Ezio Mauricio Pena, Sven Catrin
  • Publication number: 20170281622
    Abstract: The present invention relates to a compound with the following formula: formula (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 5, 2017
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir KALOUN, Serge GRISONI, Bruno GOMES, Philippe SCHMITT
  • Publication number: 20170283432
    Abstract: The present invention relates to a compound with the following formula (I): (I) or a salt and/or a pharmaceutically acceptable solvate thereof, in particular for use as a drug, in particular in the treatment of cancer, as well as to the pharmaceutical compositions that contain same and to the methods for preparing same.
    Type: Application
    Filed: September 2, 2015
    Publication date: October 5, 2017
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir KALOUN, Serge GRISONI, Anna KRUCZYNSKI, Philippe SCHMITT
  • Publication number: 20170240544
    Abstract: The present invention relates to a compound of the following formula (I) or a pharmaceutically acceptable salt and/or solvate thereof, notably for use as a drug, notably in the treatment of cancer, as well as pharmaceutical compositions containing such a compound and processes to prepare such a compound.
    Type: Application
    Filed: September 2, 2015
    Publication date: August 24, 2017
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir KALOUN, Philippe SCHMITT, Anna KRUCZYNSKI
  • Publication number: 20170002646
    Abstract: A downhole gas detection tool includes a housing; a first test module that includes a first fluid test chamber operable to fluidly couple to an annulus of a wellbore to receive a first portion of a wellbore fluid, the first test module further including an acoustic fluid sensor to measure a fluid acoustic velocity and attenuation of the first portion of the wellbore fluid received in the first fluid test chamber, and a fluid resistivity sensor to measure a fluid resistivity of the first portion of the wellbore fluid received in the first fluid test chamber; and a second test module including a second fluid test chamber operable to fluidly couple to the annulus of the wellbore to receive a second portion of the wellbore fluid, and a pressure-temperature (PT) sensor to measure at least one of a pressure or a temperature of the second portion of the wellbore fluid.
    Type: Application
    Filed: July 1, 2015
    Publication date: January 5, 2017
    Inventors: Clovis Satyro Bonavides, Denis Philippe Schmitt, Mohd Azizi Ibrahim
  • Patent number: 9085575
    Abstract: The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent.
    Type: Grant
    Filed: April 12, 2012
    Date of Patent: July 21, 2015
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Rémi Rabot, Karim Bedjeguelal, El Bachir Kaloun, Philippe Schmitt, Nicolas Rahier, Patrice Mayer, Emmanuel Fournier
  • Patent number: 8883821
    Abstract: The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.
    Type: Grant
    Filed: November 27, 2012
    Date of Patent: November 11, 2014
    Assignee: Pierre Fabre Medicament
    Inventors: El Bachir Kaloun, Karim Bedjeguelal, Rémi Rabot, Anna Kruczynski, Philippe Schmitt, Michel Perez, Nicolas Rahier
  • Patent number: 8696829
    Abstract: A brazing product includes a compacted solid and rigid material formed of a brazing flux and a filler metal as a mixture, which has mechanical strength sufficient to make it extrudable under a press with a flux mass proportion from 3 to 20%. The invention also provides a method for manufacturing a brazing product by mixing particles of filler metal and brazing powder in order to form metal particles coated with the flux, and compacting filler metal particles coated with the brazing flux.
    Type: Grant
    Filed: November 16, 2009
    Date of Patent: April 15, 2014
    Assignee: FP Soudage
    Inventors: Philippe Schmitt, Boris Bosi
  • Publication number: 20140031362
    Abstract: The present invention relates to compounds of following general formula (I): and to the pharmaceutically acceptable salts of same, the tautomers of same, the stereoisomers or mixture of stereoisomers in any proportions of same, such as a mixture of enantiomers, notably a racemic mixture, as well as to methods for preparing same and uses of same, notably as an antineoplastic agent.
    Type: Application
    Filed: April 12, 2012
    Publication date: January 30, 2014
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Rémi Rabot, Karim Bedjeguelal, El Bachir Kaloun, Philippe Schmitt, Nicolas Rahier, Patrice Mayer, Emmanuel Fournier
  • Publication number: 20130172360
    Abstract: The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.
    Type: Application
    Filed: January 27, 2012
    Publication date: July 4, 2013
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: El Bachir Kaloun, Karim Bedjeguelal, Rémi Rabot, Anna Kruczynski, Philippe Schmitt, Michel Perez, Nicolas Rahier
  • Publication number: 20100330386
    Abstract: A brazing product includes a compacted solid and rigid material formed of a brazing flux and a filler metal as a mixture, which has mechanical strength sufficient to make it extrudable under a press with a flux mass proportion from 3 to 20%. The invention also provides a method for manufacturing a brazing product by mixing particles of filler metal and brazing powder in order to form metal particles coated with the flux, and compacting filler metal particles coated with the brazing flux.
    Type: Application
    Filed: November 16, 2009
    Publication date: December 30, 2010
    Applicant: FP SOUDAGE
    Inventors: Philippe Schmitt, Boris Bosi
  • Patent number: 6326394
    Abstract: A cyclic compound of formula (I) wherein Rx groups which may be the same or different are selected from —O—(CH2)n—O— where n is an integer of from 2-6; Ry and Rz groups which may be the same or different are independently selected from hydrogen, halogen or a hydrocarbyl group; Ra together with Rb of the adjacent phenyl ring and Rc together with Rd of the adjacent phenyl ring form a group of formula —(CH2)m— or —(CH2)p—O— where m and p are integers of from 1-5, and each group Ra-Rb and Rc-Rd may be the same or different; and x is an integer of 2 or more, such as 4. Compounds of formula (I) display particular selectivity for specific ions such as potassium ions. They are useful inter alia in reactions where scavenging of a specific cation is required or as ion specific electrodes.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: December 4, 2001
    Assignee: The Secretary of State for Defence in Her Britannic Majesty's Government of the United Kingdom of Great Britain and Northern Ireland
    Inventors: Philippe Schmitt, Paul D Beer